Jul 23, 2026 04:05PM
May 21, 2026 09:17AM
May 21, 2026 06:20AM
May 20, 2026 07:00AM
Apr 2, 2026 05:00AM
Apr 2, 2026 05:00AM
Apr 2, 2026 05:00AM Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
Apr 2, 2026 05:00AM
Mar 28, 2026 03:00PM
Mar 28, 2026 03:00PM
Mar 3, 2026 07:00AM
Mar 3, 2026 07:00AM
Feb 10, 2026 06:52AM
Feb 6, 2026 07:00AM Roivant reports positive Phase 2 results for brepocitinib in sarcoidosis
Feb 6, 2026 07:00AM
Feb 6, 2026 07:00AM
Feb 6, 2026 07:00AM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM
Sep 3, 2025 01:01PM
Sep 3, 2025 01:01PM Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
Apr 21, 2025 07:02AM
Apr 21, 2025 07:00AM
Nov 12, 2024 07:00AM
Oct 28, 2024 09:25AM
Oct 28, 2024 09:25AM
Sep 18, 2024 07:30AM
Sep 18, 2024 07:30AM Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
Sep 11, 2024 06:36AM
Sep 9, 2024 07:02AM
Sep 9, 2024 07:00AM
Aug 8, 2024 07:00AM
May 30, 2024 07:00AM
Feb 13, 2024 07:00AM
Nov 13, 2023 07:00AM Roivant Reports Financial Results for the Second Quarter Ended September 30, 2023, and Provides Business Update
Nov 10, 2023 08:03AM
Nov 10, 2023 08:00AM
Aug 14, 2023 07:00AM
Jul 11, 2023 08:00AM
Jun 28, 2023 08:57AM
Jun 28, 2023 07:00AM
May 16, 2023 07:02AM Roivant(ROIV) Reports Positive Topline Results from ADORING 1, the Second Atopic Dermatitis Phase 3 Trial of VTAMA Cream, 1%
May 16, 2023 07:00AM
Mar 15, 2023 07:46AM
Mar 15, 2023 07:45AM
Mar 15, 2023 07:45AM
Mar 15, 2023 07:45AM
Feb 22, 2023 06:52AM
Feb 21, 2023 08:32PM Roivant Sciences Announces Change to its Board of Directors
Feb 21, 2023 08:32PM

326,433 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All